Abstract
Many cytotoxic drugs used to treat cancer are known to be teratogenic and mutagenic to patients. The quality of life of breast cancer patients undergoing chemotherapy is a critical area of focus in oncology care. In Nigeria, breast cancer patients are often ill-prepared to cope with the untoward effects associated with chemotherapy. The purpose of the study was to determine the awareness of cytotoxic drug side effects on the quality of life of breast cancer patients attending selected healthcare facilities.
The present study utilized a mixed-method research approach with an explanatory sequential design, using a case study framework. The study was conducted at three selected hospitals in South-East Nigeria (Imo State University Teaching Hospital, Orlu, Abia State University Teaching Hospital, Aba, and Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State) between January 2023 and April 2023. A multistage sampling technique involving simple random sampling, purposive sampling, and census sampling was adopted. Two hundred and sixty-four (264) breast cancer patients were recruited, out of which 27 participated in the qualitative part of the study. Eleven (11) in-depth interviews were conducted, and two (2) focus group discussions (FGDs) consisting of eight persons per group (a total of 16 persons) were held for data collection. Thematic analysis was used for the data.
The results illuminated two major themes: repulsive realities and holistic evaluation of life, along with eight sub-themes. The findings revealed that participants were aware of side effects such as vomiting, hair loss, and peripheral neuropathy. Coping mechanisms adopted included family support, spiritual support, and medical advice. The results also showed that patients had a generally low quality of life associated with treatment side effects, specifically in the domains of physical well-being, functionality, emotional and psychological well-being, social well-being, relationships, and financial and economic stability.
The study concluded that there is a transitional pathway from being a novice about treatment options to developing awareness, including navigating myths and misconceptions, before reaching full cognizance, alongside a general low quality of life associated with treatment side effects. It was recommended that healthcare providers provide more information about chemotherapy side effects to patients to enable informed decision-making.
References
, O., Polixeni, L., Kalliopi, M. Efrosini, Z. S. Michael, M. Eftychia, E, and Eugenia V. Factors Influencing Quality of Life in Breast Cancer Patients Six Months after the Completion of Chemotherapy. disease. 7(1): 26, 2019
8. Lewandowska, A., Grzegorz R., Tomasz L, Michal, P., Sławomir, R., Barbara L, and Joanna B. Quality of Life of Cancer Patients Treated with Chemotherapy. Int J Environ Res Public Health. 17(19): 6938. 2020
9. Katabaco, M., Matinde, R., Mwita, S., Marwa, K. and Masalu, N. Awareness of chemotherapy side effects and Attitude towards chemotherapy use among cancer medical patients attending Oncology Clinic at Bugando Medical Centre. Journal of Drug Delivery and Therapeutics 8(5): 448- 454, 2018
10. Hassen AM, Taye G, Gizaw M, Hussien FM (2019) Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. PLoS ONE 14(9): e0222629. https://doi.org/10.1371/journal.pone.0222629
11. Etikan, I., Musa, S. A. and Alkassim, R. S. (2016). Comparison of Convenience Sampling and Purposive Sampling. American Journal of Theoretical and Applied Statistics, 5(1), 1-4. doi:10.11648/j.ajtas.20160501.11
12. Clarke, P.N., Stacey, H.B. and Hanna, D. (2019): Roy’s Adaptational Model. www.nchi.n/m.org. Accessed September.
13. Chan, H. K and Ismail, S. (2016). Side effects of chemotherapy among breast cancer patients. Journal of Drug Delivery and Therapeutics 8 (5): 48- 454.
14. Katabalo, D.M., Matinde, R., Mwita, S., Marwa, K., and Masalu, N. (2018). Awareness of Chemotherapy side effects and Attitude towards Chemotherapy use among Cancer Patients attending
Oncology Clinic at Bugando Medical Centre, in Mwanza, Northern Tanzania, Journal of Drug Delivery and Therapeutics. 8(5):448-454 DOI: http://dx.doi.org/10.22270/jddt.v8i5.1900
15. Ozumba, B. C. (2018). Health-related quality of life of Breast Cancer Patients for chemotherapy in South-Eastern Nigeria. https://w.w.w.cancer.infor.org.com. Retrieved on 13thNov., 2021.
16. Kershaw T., Northouse L., Kritpracha C., Schafenacker A., Mood D. Coping strategies and quality of life in women with advanced breast cancer and their family caregivers. Psychol. Health. 2004;19:139–155
17. Emilee G., Ussher J.M., Perz J. Sexuality after breast cancer: A review. Maturitas. 2010;66:397–407
18. Kedde H., Van de Wiel H.B.M., Weijmar Schultz W.C.M., Wijsen C. Sexual dysfunction in young women with breast cancer. Supportive Care Cancer. 2013;21:271–280.
19. Den Ouden M.E.M., Pelgrum-Keurhorst M.N., Uitdehaag M.J., De Vocht H.M. Intimacy and sexuality in women with breast cancer: Professional guidance needed. Breast Cancer. 2019;26:326–332.
20. Mohammadipour M, Pidad F. Coping Strategies, Locus of Control, and Quality of Life in Patients with Early-Stage Breast Cancer. J Psychol. 2021;155(4):375-386.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2026 Authors
